Evaluation of Sensitive Analytes to Hemolysis Interference on an Automated Chemistry Analyzer
The Journal of Applied Laboratory Medicine · 2024
DOI: 10.1093/jalm/jfad124 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift The Journal of Applied Laboratory Medicine, 2024. Verfasst von Marfas Marakankadavu Parambu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory, Bassett Medical Center, Cooperstown, NY, United States. Hauptthemen laut MEDLINE: Hemolysis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Background
Hemolysis is a common reason for specimen rejection in the laboratory. Our experience suggested that hemolysis (H) flag limits are too strict for some analytes leading to unnecessary specimen rejections. This study summarizes H flags for commonly rejected analytes on the Beckman Coulter DxC 700 AU analyzer.
Methods
We evaluated analytes with low-limit H flags and high rejection rates. These included: aspartate aminotransferase (AST), alanine aminotransferase (ALT), iron (IRN), potassium (K), direct bilirubin (DBIL), magnesium (Mg), amylase (AMY), sodium (Na), gamma-glutamyltransferase (GGT), phosphorus (PHOS), albumin (ALB), alkaline phosphatase (ALKP), and lactate dehydrogenase (LDH). Five patient plasma pools without hemolysis were made from 50 patient specimens. Neat pools were analyzed to establish baseline analyte concentrations. A hemolysate was created by diluting whole blood with distilled water. Each analyte was tested after spiking each pool with the hemolysate to specific hemoglobin concentrations corresponding to manufacturer’s H flags. Percent differences were calculated between baseline pool means and each flag’s pool mean. Acceptance limits were based upon the average of the 2019 CLIA and the method precision limits. Calculated percent differences greater than the acceptance limits were considered significant.
Results
Manufacturer-defined hemolysis flags can be updated to greater than 1+ for Na, K, and AST, greater than 3+ for ALKP, and greater than 4+ for AMY and Mg. No changes were noted for the remaining analytes.
Conclusions
The hemolysis criteria set for ALKP, AMY, AST, Mg, K, and Na were updated in the Remisol Advance middleware, which led to a 56% reduction in rejected hemolyzed specimens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinical Laboratory, Bassett Medical Center, Cooperstown, NY, United States.
ORCID-Profile: Marfas Marakankadavu Parambu
Zitieren
APA
Marakankadavu Parambu, M., & Bush, V. (2024). Evaluation of Sensitive Analytes to Hemolysis Interference on an Automated Chemistry Analyzer. The Journal of Applied Laboratory Medicine. https://doi.org/10.1093/jalm/jfad124
Vancouver
Marakankadavu Parambu M, Bush V. Evaluation of Sensitive Analytes to Hemolysis Interference on an Automated Chemistry Analyzer. The Journal of Applied Laboratory Medicine. 2024. doi:10.1093/jalm/jfad124
BibTeX
@article{MarakankadavuParambu2024,
author = {Marakankadavu Parambu, Marfas and Bush, Valerie},
title = {Evaluation of Sensitive Analytes to Hemolysis Interference on an Automated Chemistry Analyzer},
journal = {The Journal of Applied Laboratory Medicine},
year = {2024},
doi = {10.1093/jalm/jfad124}
}
EUVIMED